ARIX

Arix Bioscience (ARIX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ARIX
DataOraFonteTitoloSimboloCompagnia
13/02/202409:00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Arix Bioscience plcLSE:ARIXArix Bioscience Plc
12/02/202413:53Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience shares suspended ahead of RTW takeoverLSE:ARIXArix Bioscience Plc
12/02/202413:00EQS Regulatory NewsScheme EffectiveLSE:ARIXArix Bioscience Plc
12/02/202408:00EQS Regulatory NewsSuspension of Trading in SharesLSE:ARIXArix Bioscience Plc
07/02/202412:30EQS Regulatory NewsTransaction UpdateLSE:ARIXArix Bioscience Plc
29/01/202413:15EQS Regulatory NewsResults of First General MeetingLSE:ARIXArix Bioscience Plc
24/01/202418:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
23/01/202408:00EQS Regulatory NewsUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
22/01/202417:22Alliance NewsAlliance NewsIN BRIEF: RTW Biotech completes Arix investment in takeover run-upLSE:ARIXArix Bioscience Plc
22/01/202408:00EQS Regulatory NewsUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
19/01/202412:29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:ARIXArix Bioscience Plc
19/01/202408:01EQS Regulatory NewsFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202408:00EQS Regulatory NewsUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
08/01/202418:15EQS Regulatory NewsPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
05/01/202408:00EQS Regulatory NewsPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
22/12/202312:00UK RegulatoryUpdate regarding timing of Proposed Scheme of ReconstructionLSE:ARIXArix Bioscience Plc
13/12/202308:00UK RegulatoryUnaudited NAV for November 2023LSE:ARIXArix Bioscience Plc
08/12/202308:00UK RegulatoryPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialLSE:ARIXArix Bioscience Plc
13/11/202317:00UK RegulatoryCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202309:00UK RegulatoryPortfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202308:00UK RegulatoryPDMR Notification & Director ShareholdingLSE:ARIXArix Bioscience Plc
08/11/202308:00UK RegulatoryUnaudited NAV for October 2023LSE:ARIXArix Bioscience Plc
01/11/202317:30UK RegulatoryPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102LSE:ARIXArix Bioscience Plc
01/11/202313:19Alliance NewsAlliance NewsRTW Biotech agrees "immediately accretive" Arix Bioscience takeoverLSE:ARIXArix Bioscience Plc
01/11/202308:06UK RegulatoryRTW Biotech Opportunities Ltd RTW Biotech to acquire Arix Bioscience's assetsLSE:ARIXArix Bioscience Plc
25/10/202322:55Alliance NewsAlliance NewsTRADING UPDATES: Gran Tierra completes offers, Pensana wins grantLSE:ARIXArix Bioscience Plc
24/10/202308:00UK RegulatoryPortfolio company Harpoon Therapeutics announces up to USD150 million private placementLSE:ARIXArix Bioscience Plc
06/10/202308:00UK RegulatoryUnaudited NAV for September 2023LSE:ARIXArix Bioscience Plc
27/09/202311:40Alliance NewsAlliance NewsArix Bioscience boosts net value, CEO jumping ship for PureTech HealthLSE:ARIXArix Bioscience Plc
27/09/202308:01UK RegulatoryInterim Results for the Six Months Ended 30 June 2023LSE:ARIXArix Bioscience Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ARIX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network